Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6787736 | 1.00 | LMNA (0.45) | — | |
| SCHEMBL1133347 | 0.97 | — | — | |
| SCHEMBL28162055 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL27485718 | 0.95 | — | — | |
| Ethylene Glycol SCHEMBL8008007 | 0.90 | LMNA (0.42) | — | |
| Sulfuric Acid SCHEMBL27755745 | 0.88 | LMNA (0.41) | — | |
| SCHEMBL10457871 | 0.86 | LMNA (0.39) | — | |
| Sulfuric Acid SCHEMBL28181053 | 0.86 | LMNA (0.39) | — | |
| Glycerin SCHEMBL8821888 | 0.84 | LMNA (0.38) | — | |
| Hydrochloric Acid SCHEMBL7701843 | 0.84 | LMNA (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117486878-A | Preparation method of ennafilat | 扬州市普林斯医药科技有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-113121341-A | Method for synthesizing 2, 6-diethyl-4-methyl phenylacetate | 江苏中旗科技股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-103922987-A | Zabofloxacin intermediate and synthetic method thereof. | SUZHOU TIANMA SPECIALTY CHEMICALS CO LTD | 2014-07-16 | — | — | CN | claimed |
| US-20260092072-A1 | INHIBITORS OF ALDOSE REDUCTASE | BARCLAYS BANK PLC (GB) | 2026-04-02 | — | — | US | disclosed |
| EP-4700130-A1 | PREPARATION METHOD FOR ALPHA-AMINO ACID ESTER ACYL TRANSFERASE AND USE THEREOF IN DIPEPTIDE SYNTHESIS | Asymchem Life Science (Tianjin) Co., Ltd (CN) | 2026-02-25 | — | — | EP | disclosed |
| US-12528823-B2 | Inhibitors of aldose reductase | Applied Therapeutics, Inc. (US) | 2026-01-20 | — | — | US | disclosed |
| WO-2024258613-A9 | TETRACHLOROVANCOMYCIN AND DERIVATIVES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-05-30 | — | — | WO | disclosed |
| WO-2024258613-A2 | TETRACHLOROVANCOMYCIN AND DERIVATIVES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-12-19 | — | — | WO | disclosed |
| US-12023398-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| CN-116143652-B | Alfosa intermediate and preparation method and application thereof | 四川青木制药有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118026948-A | Tri-aromatic ring compound and preparation method, pharmaceutical composition and application thereof | 中国药科大学 | 2024-05-14 | — | — | CN | disclosed |
| EP-0670837-B1 | METHOD OF PREPARING BETA-CARBOLINES | SCHERING AG (DE) | 1996-10-16 | — | — | EP | disclosed |
| US-5534541-A | THIOPHENE DERIVATIVES | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1996-07-09 | — | — | US | disclosed |
| EP-0670837-A1 | METHOD OF PREPARING -g(b)-CARBOLINES. | SCHERING AG (DE) | 1995-09-13 | — | — | EP | disclosed |
| EP-0450355-B1 | Compounds for the combat against plant diseases | DEGUSSA (DE) | 1995-08-09 | — | — | EP | disclosed |
| WO-1994012498-A1 | METHOD OF PREPARING β-CARBOLINES | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-06-09 | — | — | WO | disclosed |
| EP-0450355-A1 | Compounds for the combat against plant diseases | Degussa Aktiengesellschaft (DE) | 1991-10-09 | — | — | EP | disclosed |
| US-4761416-A | ENZYME INHIBITORS, INOTROPIC AGENTS | SYNTEX (U.S.A.) INC. (US) | 1988-08-02 | — | — | US | disclosed |
| US-4739056-A | ENZYME INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1988-04-19 | — | — | US | disclosed |
| EP-0254327-A2 | N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl) oxyalkylamides and related compounds | SYNTEX (U.S.A.) INC. (US) | 1988-01-27 | — | — | EP | disclosed |